- Case report
- Open Access
- Open Peer Review
Diagnostic difficulties of primary angiosarcoma of the breast: a case report
Journal of Medical Case Reports volume 12, Article number: 228 (2018)
Angiosarcoma of the breast is a rare tumor, which may be primary or secondary to breast surgery or irradiation. It is characterized by polymorphic and nonspecific clinical and radiological features. A pathologist plays a key role in positive and differential diagnosis and in establishing the prognosis: only a histological examination can confirm the diagnosis, and the histologic grade is the most important prognostic factor. In fact, angiosarcomas of the breast constitute a very heterogeneous group and they are classified into three grades based on the degree of differentiation. We will illustrate diagnostic challenges through this new case of primary angiosarcoma of the breast. Microscopic findings were initially interpreted as a benign vascular tumor. We will also discuss the relevant medical literature.
A 56-year-old Arabian woman presented with a palpable right breast mass that had been enlarging for 2 months, measuring 5 cm, without axillary lymphadenopathy. She had no personal or family history of breast surgery or breast irradiation. A mammography showed no evidence of spiculation. No suspicious calcifications were seen. A needle core biopsy was performed. Microscopic findings were initially interpreted as a benign vascular tumor. However, as the mass measured 5 cm, the diagnosis of angiosarcoma was more appropriate, and mastectomy without axillary dissection was performed. Microscopic examination found mild to moderately scattered pleomorphic cells, and scattered mitotic figures. It also showed papillary formations, solid foci of spindle cells, and hemorrhagic necrosis. The margins of the tumor were infiltrative. The diagnosis of primary intermediately differentiated angiosarcoma of the breast (grade II) was made. No distant metastases were found. Our patient was lost to follow-up and further treatment after mastectomy until she developed local tumor progression 4 months later.
Through this case report, we emphasize the importance of clinicopathological confrontation in angiosarcoma of the breast.
Angiosarcoma of the breast is a rare tumor. It is defined by the World Health Organization as a malignant tumor showing endothelial differentiation . It can be either primary or secondary to breast tissue irradiation or chronic lymphedema after mastectomy [1,2,3,4]. It is characterized by polymorphic and nonspecific clinical and radiological features causing diagnostic errors. Thus, a pathologist plays a key role in positive and differential diagnosis. A pathologist also plays a major role in establishing the prognosis by determining the grade. In fact, angiosarcomas of the breast are a heterogeneous group in which the grade is the most important prognostic factor. We will illustrate diagnostic challenges through this new case of primary angiosarcoma of the breast. Microscopic findings were initially interpreted as a benign vascular tumor. We will also discuss the relevant medical literature.
A 56-year-old Arabian woman presented to our institution with a palpable right breast mass (Fig. 1). Two months prior to presentation she complained of a painless right breast lump that quickly increased in size with bluish coloration of overlying skin. She had no personal or family history of cancer, breast surgery, or breast irradiation. A physical examination revealed a 5 cm ill-defined painless mass that overlapped two upper quadrants. The mass was firm and fixed to the skin which was bluish without ulceration. There was no nipple retraction, no axillary lymphadenopathy, and no signs of lymphedema. A mammography showed no evidence of spiculation. No suspicious calcifications were seen. A needle core biopsy was performed and showed anastomosing round-to-oval spaces which contained erythrocytes. Lining cells had thin, elongated but hyperchromatic nuclei, which sometimes protruded into the luminal spaces. The neoplastic vascular channels invaded adipose tissue. Immunohistochemical stains performed on the core biopsy revealed membranous reactivity of the tumor cells for CD31-related antigen and CD34-related antigen. These findings were initially interpreted as a benign vascular tumor. However, as the mass measured 5 cm, the diagnosis of angiosarcoma was more appropriate. A mastectomy without axillary dissection was performed since angiosarcoma was suspected. At gross examination, the tumor appeared ill-defined, spongy, and soft (Fig. 2). A microscopic examination revealed vascular channels lined by atypical endothelial cells with hyperchromatic, spindle-shaped or round nuclei (Fig. 3). There were mild to moderately scattered pleomorphic cells, and scattered mitotic figures (Fig. 4). Other sections showed papillary formations, solid foci of spindle cells, and hemorrhagic necrosis (Figs. 5 and 6). The margins of the tumor were infiltrative (Fig. 7). The diagnosis of primary intermediately differentiated angiosarcoma of the breast (grade II) was made. No distant metastases were found. She was lost to follow-up and further treatment after mastectomy until she developed local tumor progression 4 months later.
Discussion and conclusions
In terms of breast cancer, invasive carcinoma is by far the most common type. Angiosarcoma of the breast is a rare tumor; it accounts for 0.04% of all primary malignancies of the breast [1, 2, 5,6,7]. In our case, there was no axillary lymphadenopathy. The mammography showed no evidence of spiculation or suspicious calcifications. A biopsy showed anastomosing vascular spaces. Lining cells were almost bland. These results can be interpreted as a benign lesion. However, this did not correlate with the radiologic findings: 5 cm mass with ill-defined margins.
It may be primary or secondary to breast surgery or irradiation. Primary (de novo) angiosarcoma usually occurs in younger women [2, 5, 8] with an average age of 40 years [1, 8] compared to 67.5 years in secondary angiosarcoma . The factors involved in carcinogenesis of primary angiosarcoma are exposure to vinyl chloride, arsenic and Thorotrast (thorium dioxide), chronic irritation induced by a foreign body, and local trauma . Secondary angiosarcoma may occur in the skin and chest wall following radical mastectomy and local radiotherapy, and in the skin and breast parenchyma following breast conserving surgery and radiotherapy . Furthermore, secondary angiosarcoma may occur in the skin and soft tissues of the arm following radical mastectomy and subsequent lymphedema (axillary dissection) .
It is manifested by a painless mass [2, 5, 6], sometimes with a pulsating character . The overlying skin may have a bluish red discoloration, and there is no nipple retraction . Axillary lymph node involvement is uncommon (0 to 5% of cases)  or even absent . Mammography shows large, dense, and homogeneous mass, with sharp and sometimes polylobated contours . There are no calcifications [5, 7] or spiculation which are often seen in breast carcinomas [2, 5]. On sonography, angiosarcoma appears as a heterogeneous lesion [5, 7] with both hyperechoic and hypoechoic appearance [2, 7]. Hypoechoic areas represent hemorrhagic or necrotic changes . Color Doppler sonography reveals marked hypervascularity of the lesion [5, 7]. This hypervascular character is confirmed by computed tomography and magnetic resonance imaging with intravenously administered contrast injection . The signal on T2-weighted image is hyperintense [2, 5, 7], suggesting the presence of vascular channels containing slow flowing blood .
In some cases, diagnosis by fine-needle aspiration cytology and needle core biopsy may be difficult. Chen et al. reported a percutaneous biopsy false-negative rate of 37% . Given the vascular nature of these tumors, macrobiopsy is often difficult to perform, hence the need for surgical resection .
Only a histological examination can confirm the diagnosis. Three groups are defined according to the classification proposed by Donnell et al. . Grade I (well differentiated) contains open anastomosing vascular channels invading the breast fat and parenchyma. A single layer of endothelial cells lines these channels. The nuclei of the endothelial cells may be hyperchromatic. Solid areas of spindle cells, hemorrhage (known as “blood lakes”), and necrosis are not present. In grade II (intermediately differentiated) 75% of the tumor is composed of the well-differentiated pattern seen in grade I, but there are additional solid cellular foci or papillary formations scattered throughout the tumor. Slightly increased mitotic activity is present. In grade III, solid areas of spindle cells and papillary formations are prominent. Mitoses are common. Areas of hemorrhage and necrosis are also seen.
The constituent cells show immunoreactivity for endothelial markers: CD31, CD34, and factor VIII [1, 6]. CD31 remains the most sensitive and the most specific endothelial cell marker. The role of immunohistochemical study is to confirm the vascular nature of tumor proliferation.
For grade I and II breast angiosarcoma, the differential diagnosis includes intramammary hemangioma, angiomatosis, and pseudoangiomatous stromal hyperplasia (PASH) , especially in a core biopsy. Hemangioma is usually 2 cm or less and is sharply defined . Angiomatosis is a diffuse angioma with hemangioma and lymphangioma-like channels growing diffusely in breast tissue but sparing lobules and without nuclear atypia. Unlike angiomatosis, angiosarcoma infiltrates and dissociates breast lobules . PASH is a benign lesion comprising stromal myofibroblastic proliferation and having the appearance of anastomosing slit-like pseudovascular spaces lined by spindle-shaped cells . These spaces do not contain red cells, and have a perilobular concentric arrangement with a densely collagenous stroma . There is no destruction of the normal breast tissue, no necrosis, and no fat invasion . The myofibroblasts in PASH are positive for CD34 but are negative for factor VIII and CD31 [4, 11]. The differential diagnosis of grade I and II breast angiosarcoma is summarized in Table 1.
For grade III, sarcomatoid carcinoma and other types of high-grade sarcomas should always be considered in the differential diagnosis, hence the necessity of cytokeratin antibodies and endothelial markers . The differential diagnosis of poorly differentiated angiosarcoma is summarized in Table 2.
Angiosarcoma is an aggressive malignancy with high recurrence rates and poor overall survival . According to Rosen and colleagues’ study , grade is an important prognostic factor. In fact, the 5 years disease-free survival rate was 76%, 70%, and 15% for grade I, grade II, and grade III tumors, respectively. Primary tumor size was not significantly related to the risk of recurrence or to survival. In contrast, Zelek et al. , by reviewing eight cases of breast angiosarcoma, found that the tumor size was correlated with the rate of disease-free survival at 10 years. The prognosis was even worse when the tumor size was greater than 10 cm. Primary angiosarcoma of the breast gives metastasis mainly to lungs, liver, bones, skin, and the contralateral breast [1, 2].
There are no treatment standards for breast angiosarcomas because of their rarity . However, treatment is primarily surgical. Mastectomy with negative margins is the recommended treatment [2, 5], without axillary dissection [5, 6]. Complementary radiation therapy is necessary in case of tumorectomy . Adjuvant radiation and chemotherapy improve survival outcomes in patients with tumor size > 5 cm [14, 15]. Chemotherapy is beneficial in high-grade lesions [3, 6] and in the metastatic setting . Recently, with the exploitation of vascular endothelial growth factor (VEGF)-A and VEGF-C and the receptor VEGF-R1, anti-angiogenic treatment is certainly a highly promising therapeutic approach [2, 5].
Through this case report, we emphasize the importance of clinicopathological confrontation in angiosarcoma of the breast. This is especially true in cases of biopsy showing a well-differentiated angiosarcoma. It poses a problem of differential diagnosis with benign vascular pathology. It has a poor prognosis and presents therapeutic management difficulties.
Pseudoangiomatous stromal hyperplasia
Vascular endothelial growth factor
Fletcher CDM, MacGrogan G, Fox SB. Angiosarcoma. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. World Health Organization classification of tumours of the breast. Lyon: IARC; 2012. p. 135–6.
Bhosale SJ, Kshirsagar AY, Patil MV, Wader JV, Nangare N, Patil PP. Primary angiosarcoma of breast: a case report. Int J Surg Case Rep. 2013;4(4):362–4.
Wang XY, Jakowski J, Tawfik OW, Thomas PA, Fan F. Angiosarcoma of the breast: a clinicopathologic analysis of cases from the last 10 years. Ann Diagn Pathol. 2009;13(3):147–50.
Mac Grogan G, Vincent-Salomon A, Arnould L. Angiosarcoma of the breast, Postgraduate teaching of breast pathology; 2010. p. 241–50.
Champeaux-Orange E, Bonneau C, Raharimanana B, Favre A, Ibrahim M, Breteau N. Primary breast angiosarcoma: two case reports. Cancer Radiother. 2009;13(3):209–12.
Georgiannos SN, Sheaff M. Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook. Br J Plast Surg. 2003;56(2):129–34.
Chapiron C, Adjenou V, Arbion F, Potin J, Asquier E, Brunereau L. Breast angiosarcoma: sonographic, mammographic and MRI features. J Radiol. 2004;85(12 Pt 1):2035–8.
Hui A, Henderson M, Speakman D, Skandarajah A. Angiosarcoma of the breast: a difficult surgical challenge. Breast. 2012;21(4):584–9.
Chen KT, Kirkegaard D, Bocian J. Angiosarcoma of the breast. Cancer. 1980;46(2):368–71.
Donnell RM, Rosen PP, Lieberman PH, Kaufman RJ, Kay S, Braun DW, Kinne DW. Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol. 1981;5(7):629–42.
Michal M, Badve S, Shin SJ. Pseudoangiomatous stromal hyperplasia. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. World Health Organization classification of tumours of the breast. Lyon: IARC; 2012. p. 129–30.
Ghareeb ER, Bhargava R, Vargo JA, Florea AV, Beriwal S. Primary and radiation-induced breast angiosarcoma: clinicopathologic predictors of outcomes and the impact of adjuvant radiation therapy. Am J Clin Oncol. 2016;39(5):463–7.
Rosen PP, Kimmel M, Ernsberger D. Mammary angiosarcoma: the prognostic significance of tumor differentiation. Cancer. 1988;62(10):2145–51.
Zelek L, Llombart-Cussac A, Terrier P, Pivot X, Guinebretiere JM, Le Pechoux C, Tursz T, Rochard F, Spielmann M, Le Cesne A. Prognostic factors in primary breast sarcomas: a series of patient with long-term follow-up. J Clin Oncol. 2003;21(13):2583–8.
Yin M, Mackley HB, Drabick JJ, Harvey HA. Primary female breast sarcoma: clinicopathological features, treatment and prognosis. Sci Rep. 2016;6:31497.
Ethics approval and consent to participate
Not applicable for this section.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Mahdi, Y., Rouas, L., Malihy, A. et al. Diagnostic difficulties of primary angiosarcoma of the breast: a case report. J Med Case Reports 12, 228 (2018) doi:10.1186/s13256-018-1772-2
- Case report